Results

Total Results: 39 records

Showing results for "harms".

1. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=5
   October 12, 2023 - Purpose: To systematically review evidence for the effectiveness and harms of screening and treatment … screening trials directly addressing the effectiveness and harms of screening for FH in children and … Treatment Harms (KQ5): Harms reported in statin trials were similar in the intervention and control groups … Most trials reporting growth and development harms were limited by short duration. … Treatment Harms (KQ5): Five of the seven supplement trials reported harms with two trials reporting no

2. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=26
   June 27, 2021 - To assess comparative effectiveness and harms of opioid and nonopioid analgesics administered by emergency … quicker than giving additional IV morphine (low SOE, insufficient evidence to determine comparative harms … No studies directly evaluated clinical benefits or harms of screening versus not screening children for … There was no direct evidence on the harms of screening children for elevated blood lead levels. … No studies reported health outcomes or harms associated with interventions to reduce blood levels in

3. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=25
   June 27, 2021 - Preventive Services Task Force review on benefits and harms of risk assessment, genetic counseling, and … No studies determined optimal ages, frequencies, or harms of risk assessment. … Data Synthesis (Results): We identified no studies on the benefits or harms of prenatal HIV screening … limited, with some evidence of short-term harms. … , selection of ART regimens may help mitigate or reduce harms.

4. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=55
   March 01, 2021 - Recently Published Projects Search for more Projects Published on March 01, 2021 Benefits and Harms of … were mortality, perioperative events, complications, patient satisfaction, resource utilization, and harms … No studies reported on quality of life, patient satisfaction, or harms related to testing. … There is no evidence regarding quality of life or satisfaction, resource utilization, or harms of testing … and no evidence regarding other factors that may affect the balance of benefits and harms.

5. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=17
   November 22, 2023 - Opioid-related harms are increasing among older adults. … studies of factors associated with opioid-related outcomes and interventions to reduce opioid-related harms … opioid- related interventions in older adults, six examined screening tools to predict opioid-related harms … (including screening tools), reduce opioid-related harms and disorders, and treat existing misuse or … To evaluate the benefits and harms of selected interventional procedures for acute and chronic pain that

6. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=8
   May 30, 2023 - 04, 2023 Last updated on May 30, 2023 Objectives: Purpose: To review the evidence on benefits and harms … No studies evaluated benefits and harms of screening compared with no screening. … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatments … Harms. Evidence on the persistent psychosocial or cosmetic harms of screening was minimal. … , there are few hypothesized serious harms.

7. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=6
   July 24, 2023 - created on June 07, 2023 Last updated on June 20, 2023 Objectives: Objective: To review the benefits and harms … Observational studies and ESRs of observational studies were included for harms of pharmacotherapy. … ) and a Contextual Question (CQ): KQ 1: What are the effectiveness, comparative effectiveness, and harms … KQ 2: What are the effectiveness, comparative effectiveness, and harms of pharmacological treatments … KQ 3: What are the comparative effectiveness and harms of alternative MgSO4 treatment regimens to treat

8. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=52
   March 07, 2023 - Specifically, the review will address: (1) the (comparative) benefits and harms of IBR and AR (Key … Question [KQ] 1) (2) the (comparative) benefits and harms of timing of IBR and AR in relation to chemotherapy … and radiation therapy (KQ 2) (3) the (comparative) benefits and harms of various options for IBR (KQs … 3, 4, and 5) (4) the (comparative) benefits and harms of various flap types for AR (KQ 6). … to treat AF patients in the Medicare population, and there is uncertainty regarding the efficacy and harms

9. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=7
   June 13, 2023 - April 17, 2023 Last updated on June 01, 2023 Objectives: To evaluate the comparative effectiveness and harms … No studies evaluated benefits and harms of screening compared with no screening. … For harms, a large (N=27,830) good-quality RCT reported an RR for hepatotoxicity of 4.59 (95% CI, 2.03 … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatments … No studies evaluated benefits and harms of screening compared with no screening.

10. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=9
    January 17, 2023 - None of the included treatment trials that reported adverse effects found significant harms. … or longer-term harms. … in context of the larger body of literature on harms of inhaled therapies. … To further review harms associated with aspirin use. … Estimates of rare bleeding harms are imprecise.

11. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=49
    June 23, 2021 - compared with thiazolidinedione users; Conclusions: Comprehensive information comparing benefits and harms … Although the long-term benefits and harms of diabetes medications remain unclear, the evidence supports … The comparative balance of benefits to harms for LMWHs are superior to unfractionated heparin. … The balance of benefits to harms for combined pharmacologic plus mechanical prophylaxis versus either … SOE is moderate for minor and short-term bleeding following surgery and insufficient for other harms

12. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=47
    June 23, 2021 - Evidence on harms, effectiveness of treatments for muscle-invasive bladder cancer in patient subgroups … This report reviews the current evidence on effectiveness and harms of epidural, facet joint, and sacroiliac … stenosis, nonradicular back pain, or chronic postsurgical back pain that compared effectiveness or harms … Serious harms from injections were rare in randomized trials and observational studies, but harms reporting … associated with these strategies; and to determine whether effectiveness or harms vary in subgroups

13. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=11
    October 25, 2022 - Task Force (USPSTF) concluded that the evidence was insufficient to assess the balance of benefits and harms … There was no direct evidence on benefits and harms of glaucoma screening versus no screening. … There was no direct evidence on benefits and harms of glaucoma screening versus no screening. … Study Selection: Randomized controlled trials (RCTs) on the benefits and harms of statin therapy versus … Otherwise, there were no clear differences in benefits or harms based on intensity of statin therapy.

14. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=19
    June 27, 2021 - To assess the comparative benefits and harms across three airway management approaches (bag valve mask … intubation [ETI]) by emergency medical services in the prehospital setting and how the benefits and harms … • While harms were not always measured or reported, moderate SOE supported all available findings. … There were no differences in harms for BVM versus SGA or ETI. … Conclusions: There was no direct evidence for the clinical benefits and harms of HBV screening versus

15. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=41
    June 27, 2021 - created on June 27, 2021 Last updated on June 27, 2021 Objectives: Comparison of the benefits and harms … created on June 27, 2021 Last updated on June 27, 2021 Objectives: Comparison of the benefits and harms … created on June 27, 2021 Last updated on June 27, 2021 Objectives: Comparison of the benefits and harms

16. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=4
    October 12, 2023 - of evidence was rated low or insufficient strength to draw conclusions on comparative benefits and harms … Extraction Forms Project created on July 31, 2023 Last updated on September 13, 2023 Objectives: Do the harms … Extraction Forms Project created on July 31, 2023 Last updated on September 13, 2023 Objectives: Are harms

17. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=16
    July 29, 2022 - purpose of the review is to examine the efficacy and comparative effectiveness of both benefits and harms … Project created on August 04, 2020 Last updated on November 05, 2021 Objectives: To assess benefits and harms … To evaluate the evidence on benefits and harms of cannabinoids and similar plant-based compounds (PBCs … Other important harms (psychosis, cannabis use disorder, and cognitive effects) were not reported.

18. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=13
    September 14, 2022 - association between opioids and small improvements in short-term pain and function and increased risk of harms … Report 3 builds on Surveillance Reports 1 and 2, which identified new studies on short-term benefits and harms … , long-term benefits and harms, risk mitigation strategies, dose-dependent risks of opioids, and management … In patients with chronic pain, what are the risks of nonopioid pharmacologic agents for harms including … How do harms vary depending on: (1) the specific type or cause of pain, (2) patient demographics, (3)

19. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=45
    June 23, 2021 - This review examines the evidence on the comparative benefits and harms of noninvasive treatments for … various physical modalities) for nonradicular or radicular low back pain that addressed effectiveness or harms … Trials were not designed or powered to detect serious harms from pharmacological therapies. … Although rates appeared to be low, and there was not an increased risk of serious harms versus placebo … For nonpharmacological therapies, assessment of harms was suboptimal, but serious harms appeared rare

20. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=20
    June 27, 2021 - treatments with duration ≥5 years for mortality and metastases and ≥1 year for quality of life and harms … Harms were greater with RP than AM and mixed between EBR plus AD versus AM. 3D-Conformal EBR and AD plus … Limited evidence suggested that AS results in fewer harms than photodynamic therapy and laparoscopic … RP resulted in more harms than robotic-assisted RP. … RP reduces mortality versus WW in clinically detected CLPC but causes more harms.